Bernstein analyst Lee Hambright upgrades Stryker (NYSE:SYK) from Market Perform to Outperform and raises the price target from $288 to $295.
Morgan Stanley Downgrades Outset Medical to Equal-Weight, Lowers Price Target to $20
Morgan Stanley analyst Drew Ranieri downgrades Outset Medical (NASDAQ:OM) from Overweight to Equal-Weight and lowers the price target from $48 to $20.